Cardlytics Inc
$ 1.02
0.99%
20 Apr - close price
- Market Cap 56,172,000 USD
- Current Price $ 1.02
- High / Low $ 1.05 / 0.98
- Stock P/E N/A
- Book Value -0.12
- EPS -1.95
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.09 %
- ROE -3.26 %
- 52 Week High 3.28
- 52 Week Low 0.66
About
Cardlytics, Inc. operates an advertising platform within financial institutions' digital channels including online, mobile, email, and various real-time notifications in the United States and the United Kingdom. The company is headquartered in Atlanta, Georgia.
Analyst Target Price
$1.04
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-03 | 2025-11-04 | 2025-07-28 | 2025-04-30 | 2025-03-12 | 2024-11-06 | 2024-08-07 | 2024-05-08 | 2024-03-14 | 2023-11-08 | 2023-08-01 | 2023-05-04 |
| Reported EPS | 0.03 | -0.07 | -0.13 | -0.21 | -0.31 | -0.15 | -0.15 | -0.09 | 0.14 | 0.01 | -0.24 | -0.25 |
| Estimated EPS | -0.2767 | -0.3467 | -0.39 | -0.2667 | -0.47 | -0.24 | -0.13 | -0.11 | 0.12 | -0.01 | -0.35 | -0.56 |
| Surprise | 0.3067 | 0.2767 | 0.26 | 0.0567 | 0.16 | 0.09 | -0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.31 |
| Surprise Percentage | 110.8421% | 79.8096% | 66.6667% | 21.2598% | 34.0426% | 37.5% | -15.3846% | 18.1818% | 16.6667% | 200% | 31.4286% | 55.3571% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CDLX
2026-04-17 04:10:19
Cardlytics has successfully repaid its 2020 convertible senior notes that were due in 2025. This action demonstrates the company's financial discipline and ability to manage its debt obligations effectively. The repayment signifies a positive step in Cardlytics' financial strategy.
2026-04-17 02:39:06
Cardlytics Inc (CDLX) held its Q3 2025 earnings call, revealing mixed results. The company successfully mitigated billing drop from a major partner's content restrictions by shifting volume to others and expanded its network with three new US partners, including OpenTable. Despite a 21% year-over-year improvement in return on ad spend and 22% revenue growth in the UK, total billings decreased by 20.3% and revenue by 22.4% primarily due to continued content restrictions from its largest FY partner, which is also expected to impact Q4.
2026-04-13 22:09:11
Cardlytics Inc. offers a unique investment opportunity in personalized marketing, leveraging anonymized consumer spending data from bank partners for targeted advertising campaigns. This business model positions the company at the intersection of fintech and ad tech, providing stable, recurring revenue from long-term bank contracts. For U.S. investors, Cardlytics offers exposure to the banking sector's digital transformation without direct bank stock ownership, benefiting from economic recoveries and increased transaction flows.
2026-04-13 21:40:15
Cardlytics Inc. leverages anonymized consumer spending data from bank partners to deliver hyper-targeted advertising, offering a unique play on personalized marketing. This model, which embeds incentives directly into bank apps, provides stability through recurring revenue from long-term bank contracts. For U.S. and English-speaking market investors, Cardlytics presents an opportunity to invest in fintech and ad tech, with growth driven by rising mobile banking penetration, AI enhancements, and strategic partnerships.
2026-04-09 20:09:59
Cardlytics (NASDAQ: CDLX) is asking shareholders to vote on a potential reverse stock split, director elections, and executive compensation at its May 20, 2026 annual meeting. The proposed reverse stock split, ranging from 1-for-5 to 1-for-15, aims to help the company meet Nasdaq's minimum bid price requirement. Shareholders will also vote on electing three Class II directors and ratifying Deloitte & Touche LLP as the 2026 auditor.
2026-04-07 20:10:47
Cardlytics Inc. (CDLX) has filed a Form 144, indicating a proposed sale of 50,000 common shares by an affiliate, reported on March 25, 2026. The filing also details restricted stock vesting events for 6,898 shares on July 1, 2024, and 13,102 shares on August 14, 2024, both related to compensation. Fidelity Brokerage Services LLC is listed as the broker for these transactions.
